A global survey of companies pursuing 'nanomedicine' indicates that nanotechnology is taking root in the drug and medical device industry.
References
European Science Foundation. Nanomedicine. An ESF–European Medical Research Councils (EMRC) Forward Look Report. (European Science Foundation, Strasbourg, 2005).
European Science and Technology Observatory. Nanobiotechnology in the Medical Sector – Drivers for Development and Possible Impacts (Institute for Prospective Technological Studies, October 2006).
Duncan, R. Nanomedicines in action. Pharm. J. 273, 485–488 (2004).
Royal Society & Royal Academy of Engineering. Nanoscience and Nanotechnologies: Opportunities and Uncertainties (Royal Society, London, 2004).
Sato, M. & Webster, T.J. Nanobiotechnology: implications for the future of nanotechnology in orthopedic applications. Expert Rev. Med. Devices 1, 105–114 (2004).
European Commission. Nanosciences and Nanotechnologies: An Action Plan for Europe 2005–2009 COM (European Commission, Brussels, 2005). http://cordis.europa.eu/nanotechnology/actionplan.
Allen, T.M. & Cullis, P.R. Drug delivery systems: entering the mainstream. Science 303, 1818–1822 (2004).
Duncan, R. Polymer therapeutics into the 21st Century, in Controlled Drug Delivery. ACS Symposium Series, vol. 752 (eds. Park, K. & Mrsny, R.J.) 350–363 (American Chemical Society, Washington, DC, 2000).
Maurer, N., Fenske, D.B. & Cullis P.R. Developments in liposomal drug delivery systems. Expert Opin. Biol. Ther. 1, 923–947 (2001).
Acknowledgements
Data presented were largely derived from the European Science and Technology Observation network (ESTO) study Nanobiotechnology in the Medical Sector—Drivers for Development and Possible Impacts funded by the European Commission through ESTO. We are grateful to our anonymous interviewees who all gave generously of their time. We thank Yves Verbandt at the European Patent Office for the extensive analysis of the nanomedicine patent data. Thanks also to Jascha Knoche for preparing the figures.
Author information
Authors and Affiliations
Supplementary information
Rights and permissions
About this article
Cite this article
Wagner, V., Dullaart, A., Bock, AK. et al. The emerging nanomedicine landscape. Nat Biotechnol 24, 1211–1217 (2006). https://doi.org/10.1038/nbt1006-1211
Issue Date:
DOI: https://doi.org/10.1038/nbt1006-1211
- Springer Nature America, Inc.
This article is cited by
-
Investigating hybrid nanoparticles for drug delivery in multi-stenosed catheterized arteries under magnetic field effects
Scientific Reports (2024)
-
Anti-cancer Activity of Biogenic Nat-ZnO Nanoparticles Synthesized Using Nyctanthes arbor-tristis (Nat) Flower Extract
Applied Biochemistry and Biotechnology (2024)
-
Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress
Journal of Nanobiotechnology (2023)
-
Chemoprevention of bilirubin encephalopathy with a nanoceutical agent
Pediatric Research (2023)
-
Clinical symbiosis of hybrid nanoparticles and induced magnetic field on heat and mass transfer in multiple stenosed artery with erratic thrombosis
Scientific Reports (2023)